EAM
MED icon

EULAV Asset Management’s Medifast MED Stock Holding History

EULAV Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,400
Closed -$352K – 190
2023
Q1 		$352K Sell
3,400
-3,400
-50% -$377K 0.01% 192
2022
Q4 		$784K Hold
6,800
– – 0.03% 191
2022
Q3 		$737K Sell
6,800
-13
-0.2% -$1.86K 0.03% 193
2022
Q2 		$1.23M Buy
6,813
+399
+6% +$71.4K 0.05% 193
2022
Q1 		$1.09M Buy
6,414
+2
+0% +$377 0.03% 210
2021
Q4 		$1.38M Buy
6,412
+1
+0% +$207 0.03% 211
2021
Q3 		$1.24M Hold
6,411
– – 0.03% 208
2021
Q2 		$1.81M Hold
6,411
– – 0.05% 200
2021
Q1 		$1.36M Hold
6,411
– – 0.04% 220
2020
Q4 		$1.26M Buy
6,411
+11
+0.2% +$1.94K 0.03% 227
2020
Q3 		$1.05M Sell
6,400
-16
-0.2% -$2.63K 0.03% 231
2020
Q2 		$890K Buy
6,416
+16
+0.3% +$1.47K 0.03% 237
2020
Q1 		$400K Sell
6,400
-6,200
-49% -$564K 0.02% 246
2019
Q4 		$1.38M Sell
12,600
-5,700
-31% -$552K 0.05% 234
2019
Q3 		$1.9M Hold
18,300
– – 0.07% 219
2019
Q2 		$2.35M Buy
18,300
+6,900
+61% +$959K 0.09% 201
2019
Q1 		$1.49M Hold
11,400
– – 0.06% 227
2018
Q4 		$1.43M Hold
11,400
– – 0.07% 215
2018
Q3 		$2.53M Hold
11,400
– – 0.11% 178
2018
Q2 		$1.83M Buy
11,400
+900
+9% +$115K 0.08% 201
2018
Q1 		$981K Buy
+10,500
New +$785K 0.05% 228

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

EULAV Asset Management's MED Position: Q2 2023 in Review

EULAV Asset Management sold out of Medifast (MED) in Q2 2023, closing a stake of 3,400 shares — an estimated $352K sold.

EULAV Asset Management first reported a position in MED in Q1 2018 and held it in 21 quarters. The position peaked at $2.53M in Q3 2018. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • EULAV Asset Management reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • EULAV Asset Management sold 3,400 Medifast shares in Q2 2023, an estimated $352K.
  • EULAV Asset Management first reported a position in Medifast in Q1 2018 and held it in 21 quarters.
  • EULAV Asset Management's Medifast position peaked at $2.53M in Q3 2018.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on EULAV Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.